Send to a Friend Font Size: Increase Decrease

NAGE and EVO Related Headlines

Aug 3, 2026 08:33AM Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
Aug 3, 2026 08:32AM Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

NAGE and EVO Related Press Releases

Aug 3, 2026 08:32AM Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

NAGE and EVO Related SEC Filings